Potassium Chloride

Oral correction of fluid and electrolyte loss in infants aged 3 months upwards, children and adults. Treatment of watery diarrhoea of various aetiologies including gastroenteritis in all age groups from 3 months upwards. Dioralyte Relief is particularly recommended in the case of too loose or frequent stools where it enables over-loose stools to revert to normal.

1 INDICATIONS AND USAGE Potassium Chloride Extended-Release Tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.

Potassium Chloride Extended-Release Tablets are a potassium salt, indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.

(1)

Potassium Chloride Injection is indicated for:  treatment of potassium deficiency states where hypokalemia is severe. 2 mEq/L in the presence of metabolic acidosis and treatment with sodium bicarbonate or insulin is imminent. 0 mEq/L is necessary to minimize ventricular arrhythmias.

 cautious treatment to abolish arrhythmias of cardiac glycoside toxicity precipitated by a loss of potassium. This regimen should not be used in patients with atrioventricular block. This highly concentrated, ready-to-use potassium chloride injection is intended for the rapid correction of hypokalemia and for potassium supplementation in fluid restricted patients who cannot accommodate additional volumes of fluid associated with potassium solutions of lower concentration.

1 Pediatrics (< 16 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use. 2 Geriatrics (> 65 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use.